Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard T Bryan

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
BJU International|October 30, 2020
The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshotSarah Spencer-Bowdage, Beth Russell, Jeannie Rigby, et al.
BJUI Compass|August 10, 2022
The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemicBeth Russell, Sarah Spencer-Bowdage, Jeannie Rigby, et al.
European Urology Oncology|April 12, 2022
Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNADouglas G Ward, Laura Baxter, Sascha Ott, et al.
Clinical Epigenetics|August 12, 2025
Detection of genome-wide methylation changes in bladder cancer by long-read sequencing of urinary DNAAnshita Goel, Benjamin J Tura, Joanne D Stockton, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment After Transurethral ResectionErik Veskimae, Selvarani Subbarayan, Riccardo Campi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarkerRichard Morgan, Richard T Bryan, Saqib Javed, et al.
Plos One|September 3, 2015
Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder CancerMark O Kitchen, Richard T Bryan, Kim E Haworth, et al.
BMJ Oncology|January 31, 2025
Boosting and broadening recruitment to UK cancer trials: towards a blueprint for actionVeronica Nanton, Richard T Bryan, Anne M Pope, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 7, 2017
Tar, nicotine and carbon monoxide yield of UK cigarettes and the risk of non-muscle-invasive and muscle-invasive bladder cancerFrits H M van Osch, Charlotte G G M Pauwels, Sylvia H J Jochems, et al.
BMJ Open|September 28, 2019
Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancerHarriet Wylie, Fidelma Cahill, Aida Santaolalla, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
BJU International|October 30, 2020
The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshotSarah Spencer-Bowdage, Beth Russell, Jeannie Rigby, et al.
BJUI Compass|August 10, 2022
The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemicBeth Russell, Sarah Spencer-Bowdage, Jeannie Rigby, et al.
European Urology Oncology|April 12, 2022
Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNADouglas G Ward, Laura Baxter, Sascha Ott, et al.
Clinical Epigenetics|August 12, 2025
Detection of genome-wide methylation changes in bladder cancer by long-read sequencing of urinary DNAAnshita Goel, Benjamin J Tura, Joanne D Stockton, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment After Transurethral ResectionErik Veskimae, Selvarani Subbarayan, Riccardo Campi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarkerRichard Morgan, Richard T Bryan, Saqib Javed, et al.
Plos One|September 3, 2015
Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder CancerMark O Kitchen, Richard T Bryan, Kim E Haworth, et al.
BMJ Oncology|January 31, 2025
Boosting and broadening recruitment to UK cancer trials: towards a blueprint for actionVeronica Nanton, Richard T Bryan, Anne M Pope, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 7, 2017
Tar, nicotine and carbon monoxide yield of UK cigarettes and the risk of non-muscle-invasive and muscle-invasive bladder cancerFrits H M van Osch, Charlotte G G M Pauwels, Sylvia H J Jochems, et al.
BMJ Open|September 28, 2019
Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancerHarriet Wylie, Fidelma Cahill, Aida Santaolalla, et al.
Pageof 14